Long-Term Functional and Clinical Follow-Up of Patients With Heart Failure With Recovered Left Ventricular Ejection Fraction After &bgr;-Blocker Therapy

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Circulation: Heart Failure

• Publication date

  2014-02-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/CIRCHEARTFAILURE.113.000813PMID 24563449
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, Ameri

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, Ameri

  2013cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 = Akut ve Kronik Kalp Yetersizligi Tani ve Tedavisine Yönelik 2012 ESC Kilavuzu

  2012cited by this paper
• Myocardial recovery and the failing heart: myth, magic, or molecular target?

  2012cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  2012cited by this paper
• Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.

  2012cited by this paper
• Longitudinal Changes in Ejection Fraction in Heart Failure Patients With Preserved and Reduced Ejection Fraction

  2012cited by this paper
• Heart failure with recovered ejection fraction: a distinct clinical entity.

  2011influential reference
• Cardiac-resynchronization therapy for mild-to-moderate heart failure.

  2010cited by this paper
• The effects of β-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis

  2008cited by this paper
• The effects of beta-blockers in patients with stable chronic heart failure. Predictors of left ventricular ejection fraction improvement and impact on prognosis.

  2007influential reference
• Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio

  2005cited by this paper
• Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial.

  2005cited by this paper
• Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance.

  2003cited by this paper
• Clinical benefits of low serum digoxin concentrations in heart failure.

  2002cited by this paper
• Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol.

  2000cited by this paper
• Differential Effects of β-Blockers in Patients With Heart Failure

  2000cited by this paper
• Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure.

  2000cited by this paper
• Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials.

  1998cited by this paper
• Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade.

  1995cited by this paper
• Prediction of improvement in recent onset cardiomyopathy after referral for heart transplantation.

  1994cited by this paper

• Left ventricular reverse remodeling: A predictor of survival in chagasic cardiomyopathy patients with a reduced ejection fraction

  2025cites this paper
• Reverse Remodelling, Myocardial Recovery and Remission in Heart Failure with Reduced Ejection Fraction: Clinical Implications and Management Strategies

  2025cites this paper
• Beyond initial recovery: Heart failure with transient vs sustained improvement in left ventricular ejection fraction

  2025cites this paper
• Heart failure improvement, remission, and recovery: A European Journal of Heart Failure expert consensus document

  2025cites this paper
• Outcomes in Heart Failure With Improved Ejection Fraction Following Implantable Cardioverter-Defibrillator Placement for Primary Prevention

  2025cites this paper
• Impaired myocardial work in heart failure with improved ejection fraction: A post hoc analysis from the CATHEDRAL-HF trial.

  2025cites this paper
• Reviving the Failing Heart: Contractile Reserve and Remodeling Reversal

  2025cites this paper
• LIPCAR levels in plasma-derived extracellular vesicles is associated with left ventricle remodeling post-myocardial infarction

  2024cites this paper
• Incidence, progression, and outcomes of heart failure with improved ejection fraction: The added value of longitudinally assessed ejection fraction.

  2024cites this paper
• Characteristics, Predictors, and Clinical Outcomes in Heart Failure With Reduced Ejection Fraction According to a 1‐Year Left Ventricular Ejection Fraction Following Sacubitril/Valsartan Treatment

  2024cites this paper
• Predictors and Prognostic Factors of Heart Failure with Improved Ejection Fraction

  2024cites this paper
• Heart Failure With Improved Ejection Fraction: Prevalence, Predictors, and Guideline-Directed Medical Therapy

  2024cites this paper
• Long-Term Trajectories of Biomarkers, Functional, and Echocardiographic Parameters in Patients with Chronic Heart Failure from Dilated or Ischaemic Cardiomyopathy

  2023cites this paper
• Clinical Relevance of the LVEDD and LVESD Trajectories in HF Patients With LVEF < 35%

  2022cites this paper
• Extent of Ejection Fraction Improvement After Revascularization Associated with Outcomes Among Patients with Ischemic Left Ventricular Dysfunction

  2022cites this paper
• Heart failure with recovered ejection fraction: Current understanding and future prospects.

  2022cites this paper
• Clinical impacts of sacubitril/valsartan on patients eligible for cardiac resynchronization therapy

  2022influential citation
• Quality of life in patients with heart failure and improved ejection fraction: one‐year changes and prognosis

  2022cites this paper
• Heart failure ejection fraction class conversions: impact of biomarkers, co‐morbidities, and pharmacotherapy

  2022cites this paper
• Development and Validation of a Novel Nomogram to Predict Improved Left Ventricular Ejection Fraction in Patients With Heart Failure After Successful Percutaneous Coronary Intervention for Chronic Total Occlusion

  2022influential citation
• Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure

  2022cites this paper
• Clinical characteristics, predictors, and outcomes of heart failure with improved ejection fraction.

  2022cites this paper
• Mitophagy Regulation Following Myocardial Infarction

  2022cites this paper
• Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes

  2021cites this paper
• Body Mass Index: An Effective Predictor of Ejection Fraction Improvement in Heart Failure

  2021cites this paper
• Beta-blockers are associated with reverse remodeling in patients with dilated cardiomyopathy and mid-range ejection fraction

  2021cites this paper
• Characteristics and outcomes of heart failure with recovered left ventricular ejection fraction

  2021cites this paper
• Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of Cardiology

  2021cites this paper
• Beta‐Blocker Use Is Associated With Prevention of Left Ventricular Remodeling in Recovered Dilated Cardiomyopathy

  2021cites this paper
• Rationale and Study Design of the Withdrawal of Spironolactone for Heart Failure with Improved Left Ventricular Ejection Fraction

  2021cites this paper
• Association of early versus delayed normalisation of left ventricular ejection fraction with mortality in ischemic cardiomyopathy

  2021cites this paper
• Clinical significance of ischemia-like electrocardiographic finding during heart failure treatment on left ventricular recovery in patients with non-ischemic dilated cardiomyopathy.

  2021cites this paper
• Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel.

  2020cites this paper
• Late gadolinium enhancement for re‐worsening left ventricular ejection fraction in patients with dilated cardiomyopathy

  2020cites this paper
• Relationship between left ventricular ejection fraction and cardiovascular outcomes following hospitalization for heart failure: insights from the RELAX‐AHF‐2 trial

  2020cites this paper
• Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition

  2020cites this paper
• Long-term LVEF trajectories in patients with type 2 diabetes and heart failure: diabetic cardiomyopathy may underlie functional decline

  2020cites this paper
• HEART FAILURE WITH MID-RANGE LEFT VENTRICULAR EJECTION FRACTION.

  2020cites this paper
• Noncoding RNAs in Cardiac Autophagy following Myocardial Infarction

  2019cites this paper
• Anemia and iron deficiency in heart failure: a review of echocardiographic features

  2019cites this paper
• Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction

  2019cites this paper
• Cardiac Remodeling: The Course Towards Heart Failure-II. Diagnostic and Therapeutic Approaches

  2019cites this paper
• Is Any Patient with Chronic Heart Failure Receiving the Right Dose of the Right Beta-Blocker in Primary Care?

  2019cites this paper
• Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study.

  2019cites this paper
• Targeted Mono-Therapy for Newly Diagnosed Dilated Cardiomyopathy.

  2019cites this paper
• Can we turn heart failure into heart success by studying myocardial remission?

  2019cites this paper
• Heterogeneous Outcomes of Heart Failure with Better Ejection Fraction

  2019cites this paper
• Contemporary approach to treating heart failure.

  2019cites this paper
• Dilated cardiomyopathy with re-worsening left ventricular ejection fraction

  2018cites this paper
• Expression and Implication of Clusterin in Left Ventricular Remodeling After Myocardial Infarction

  2018cites this paper
• Heart Failure with Recovered EF and Heart Failure with Mid-Range EF: Current Recommendations and Controversies

  2018cites this paper
• Reverse remodelling and myocardial recovery in heart failure

  2018cites this paper
• Early Recognition of Heart Failure: A Call for Action.

  2018cites this paper
• Trayectorias dinámicas de la fracción de eyección ventricular izquierda en la­insuficiencia cardíaca

  2018influential citation
• Characteristics and prognosis of heart failure with improved compared with persistently reduced ejection fraction: A systematic review and meta-analyses

  2018cites this paper
• Transition of Left Ventricular Ejection Fraction in Heart Failure.

  2018cites this paper
• Remission and Recovery in Heart Failure

  2018cites this paper
• Baseline Longitudinal Strain Predicts Recovery of Left Ventricular Ejection Fraction in Hospitalized Patients With Nonischemic Cardiomyopathy

  2018cites this paper
• A severity index study of long‐term prognosis in patients with chronic heart failure

  2018cites this paper
• Heart Failure With Improved Ejection Fraction: Is it Possible to Escape One's Past?

  2018cites this paper
• Dynamic Trajectories of Left Ventricular Ejection Fraction in Heart Failure.

  2018cites this paper
• Sustained Cardiac Recovery Hinges on Timing and Natural History of Underlying Condition

  2018cites this paper
• The Effect of Left Ventricular Assist Device Therapy on Cardiac Biomarkers: Implications for the Identification of Myocardial Recovery

  2018cites this paper
• Angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: Prevalence, correlates, and prognostic impact (from the CORONOR study).

  2017cites this paper
• Left ventricular assist device-induced reverse remodeling: it’s not just about myocardial recovery

  2017cites this paper
• New guidelines, new recommendations! But what is really new? A pragmatic interpretation of the 2016 European guidelines for the management of chronic heart failure.

  2017cites this paper
• Recovered heart failure with reduced ejection fraction and outcomes: a prospective study

  2017cites this paper
• Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial.

  2017cites this paper
• Heart Failure With a Better Ejection Fraction: Why Should We Care?

  2016influential citation
• Incidence and prognosis implications of long term left ventricular reverse remodeling in patients with dilated cardiomyopathy.

  2016cites this paper
• Incidence and timing of left ventricular reverse remodeling: Key information for the management of patients with new onset left ventricular systolic dysfunction.

  2016cites this paper
• Heart Failure With Improved Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival Results From the Valsartan Heart Failure Trial

  2016influential citation
• Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.

  2016cites this paper
• Impact of Improved Left Ventricular Systolic Function on the Recurrence of Ventricular Arrhythmia in Heart Failure Patients With an Implantable Cardioverter‐Defibrillator

  2016cites this paper
• [Air pollution].

  2016cites this paper
• Pharmacologic and Endovascular Reversal of Left Ventricular Remodeling.

  2016cites this paper
• Heart Failure with Recovered Ejection Fraction in a Cohort of Elderly Patients with Chronic Heart Failure

  2016cites this paper
• Heart Failure and Midrange Ejection FractionCLINICAL PERSPECTIVE

  2016cites this paper
• Management of Patients With Recovered Systolic Function.

  2016cites this paper
• Regression of left ventricular hypertrabeculation is associated with improvement in systolic function and favorable prognosis in adult patients with non-ischemic cardiomyopathy.

  2016cites this paper
• Cœur et pollution particulaire

  2016cites this paper
• Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction.

  2016cites this paper
• Cardiac Adrenergic Nervous System and Left Ventricular Remodeling

  2015cites this paper
• НЕЙРОГУМОРАЛЬНЫЕ МОДУЛЯТОРЫ В ЛЕЧЕНИИ БОЛЬНЫХ С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ

  2015cites this paper
• Systems Genomics Identifies a Key Role for Hypocretin/Orexin Receptor-2 in Human Heart Failure.

  2015cites this paper
• Improved Long-Term Prognosis of Dilated Cardiomyopathy With Implementation of Evidenced-Based Medication - Report From the CHART Studies - .

  2015cites this paper
• Persistent Recovery of Normal Left Ventricular Function and Dimension in Idiopathic Dilated Cardiomyopathy During Long‐Term Follow‐up: Does Real Healing Exist?

  2015cites this paper
• Characterizing Heart Failure in the Ventricular Volume Domain

  2015cites this paper
• Multimarker Proteomic Profiling for the Prediction of Cardiovascular Mortality in Patients with Chronic Heart Failure

  2015cites this paper
• Heart failure with better ejection fraction: a modern diagnosis.

  2014cites this paper
• Reversed reverse remodeling: can biomonitoring solve the clinical conundrum of the 3Rs?

  2014cites this paper